Skip Navigation Links1st Order Pharmaceuticals

​​1st Order Pharmaceuticals (1OP) is a development-stage pharmaceutical company focused on advancing 1OP-2198, an IND-ready small molecule potassium channel opener (KCNQ2/3), for unmet medical and orphan indications in neurology and neuro-ophthalmology.


We use accepted scientific principles in pharmacokinetic and pharmacodynamic (PK/PD) modeling to enable intelligent drug development strategies that

  1. Reduces the cost of developing new therapeutics for serious diseases
  2. Decreases the time to availability of important new medicines for patients
  3. Improves our understanding of the drug's behavior to reduce the risks associated with drug development and general clinical use.​

This website is under development...more info to come​